FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

XERIS PHARMACEUTICALS INC: cashflow_financing

One fact, its scope and the complete path back to the official record.

Period: 2019-01-01 – 2019-03-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/338da605-1f87-4f9b-bf9d-d8e4a8d7d520

Reported value

$56.147M{"amount": 56147000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Entity
XERIS PHARMACEUTICALS INC
Metric
cashflow_financing
Period
2019-01-01 – 2019-03-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001346302-19-000019 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T12:52:11.062419+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001346302/cashflow-financing/2019-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.